Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.43
-$1.34 (-7.1%)
Closing Price on November 6, 2024
TEVA Articles
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Published:
Last Updated:
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
Published:
Last Updated:
Teva and Regeneron both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of fasinumab in patients with chronic pain from osteoarthritis...
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Blue Apron, Energy Transfer Partners, Funko, Symantec, Tesla, Teva Pharmaceutical and TripAdvisor.
Published:
Last Updated:
Teva shares stumbled after it released its most recent quarterly results before the markets opened on Thursday.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Abbott Laboratories, Honeywell, Tiffany and Zimmer Biomet.
Published:
Last Updated:
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Broadcom, Deere, Generac, McDermott, NetApp, NRG Energy, Petrobras, Teva Pharmaceutical and Tiffany.
Published:
Last Updated:
Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.
Published:
Last Updated: